These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16732297)

  • 1. Permeability properties of tumor surrogate blood vessels induced by VEGF-A.
    Nagy JA; Feng D; Vasile E; Wong WH; Shih SC; Dvorak AM; Dvorak HF
    Lab Invest; 2006 Aug; 86(8):767-80. PubMed ID: 16732297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.
    Feng D; Nagy JA; Hipp J; Dvorak HF; Dvorak AM
    J Exp Med; 1996 May; 183(5):1981-6. PubMed ID: 8642308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
    Feng D; Nagy JA; Dvorak AM; Dvorak HF
    Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.
    Kohn S; Nagy JA; Dvorak HF; Dvorak AM
    Lab Invest; 1992 Nov; 67(5):596-607. PubMed ID: 1279271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors.
    Feng D; Nagy JA; Brekken RA; Pettersson A; Manseau EJ; Pyne K; Mulligan R; Thorpe PE; Dvorak HF; Dvorak AM
    J Histochem Cytochem; 2000 Apr; 48(4):545-56. PubMed ID: 10727296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.
    Dvorak HF; Sioussat TM; Brown LF; Berse B; Nagy JA; Sotrel A; Manseau EJ; Van de Water L; Senger DR
    J Exp Med; 1991 Nov; 174(5):1275-8. PubMed ID: 1940805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium.
    Qu-Hong ; Nagy JA; Senger DR; Dvorak HF; Dvorak AM
    J Histochem Cytochem; 1995 Apr; 43(4):381-9. PubMed ID: 7534783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation.
    Dvorak AM; Kohn S; Morgan ES; Fox P; Nagy JA; Dvorak HF
    J Leukoc Biol; 1996 Jan; 59(1):100-15. PubMed ID: 8558058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators.
    Feng D; Nagy JA; Pyne K; Hammel I; Dvorak HF; Dvorak AM
    Microcirculation; 1999 Mar; 6(1):23-44. PubMed ID: 10100187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
    Dvorak HF; Brown LF; Detmar M; Dvorak AM
    Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.
    Sundberg C; Nagy JA; Brown LF; Feng D; Eckelhoefer IA; Manseau EJ; Dvorak AM; Dvorak HF
    Am J Pathol; 2001 Mar; 158(3):1145-60. PubMed ID: 11238063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.
    Sitohy B; Chang S; Sciuto TE; Masse E; Shen M; Kang PM; Jaminet SC; Benjamin LE; Bhatt RS; Dvorak AM; Nagy JA; Dvorak HF
    Am J Pathol; 2017 Oct; 187(10):2337-2347. PubMed ID: 28736316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels.
    Vasile E; Qu-Hong ; Dvorak HF; Dvorak AM
    J Histochem Cytochem; 1999 Feb; 47(2):159-67. PubMed ID: 9889252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
    Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
    EXS; 1997; 79():233-69. PubMed ID: 9002222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chapter 3. The adenoviral vector angiogenesis/lymphangiogenesis assay.
    Nagy JA; Shih SC; Wong WH; Dvorak AM; Dvorak HF
    Methods Enzymol; 2008; 444():43-64. PubMed ID: 19007660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets.
    Nagy JA; Dvorak HF
    Clin Exp Metastasis; 2012 Oct; 29(7):657-62. PubMed ID: 22692562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.
    Pettersson A; Nagy JA; Brown LF; Sundberg C; Morgan E; Jungles S; Carter R; Krieger JE; Manseau EJ; Harvey VS; Eckelhoefer IA; Feng D; Dvorak AM; Mulligan RC; Dvorak HF
    Lab Invest; 2000 Jan; 80(1):99-115. PubMed ID: 10653008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.
    Sitohy B; Nagy JA; Jaminet SC; Dvorak HF
    Cancer Res; 2011 Nov; 71(22):7021-8. PubMed ID: 21937680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular permeability and pathological angiogenesis in caveolin-1-null mice.
    Chang SH; Feng D; Nagy JA; Sciuto TE; Dvorak AM; Dvorak HF
    Am J Pathol; 2009 Oct; 175(4):1768-76. PubMed ID: 19729487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
    Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.